907 related articles for article (PubMed ID: 23155281)
61. Malignant pleural effusion in the palliative care setting.
Arber A; Clackson C; Dargan S
Int J Palliat Nurs; 2013 Jul; 19(7):320, 322-5. PubMed ID: 24273808
[TBL] [Abstract][Full Text] [Related]
62. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.
Steger V; Mika U; Toomes H; Walker T; Engel C; Kyriss T; Ziemer G; Friedel G
Ann Thorac Surg; 2007 Jun; 83(6):1940-5. PubMed ID: 17532375
[TBL] [Abstract][Full Text] [Related]
63. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.
Debeljak A; Kecelj P; Triller N; Letonja S; Kern I; Debevec L; Rozman A
J BUON; 2006; 11(4):463-7. PubMed ID: 17309178
[TBL] [Abstract][Full Text] [Related]
64. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
[TBL] [Abstract][Full Text] [Related]
65. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
66. Talc mediates angiostasis in malignant pleural effusions via endostatin induction.
Nasreen N; Mohammed KA; Brown S; Su Y; Sriram PS; Moudgil B; Loddenkemper R; Antony VB
Eur Respir J; 2007 Apr; 29(4):761-9. PubMed ID: 17251235
[TBL] [Abstract][Full Text] [Related]
67. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
Walter M; Türler A; Schmitz-Rixen T
Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
[TBL] [Abstract][Full Text] [Related]
68. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
69. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis.
Olden AM; Holloway R
J Palliat Med; 2010 Jan; 13(1):59-65. PubMed ID: 19839739
[TBL] [Abstract][Full Text] [Related]
70. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
Corcoran JP; Hallifax RJ; Mercer RM; Yousuf A; Asciak R; Hassan M; Piotrowska HE; Psallidas I; Rahman NM
Chest; 2018 Nov; 154(5):1115-1120. PubMed ID: 30243566
[TBL] [Abstract][Full Text] [Related]
71. Postoperative outcome after palliative treatment of malignant pleural effusion.
Markowiak T; Ried M; Großer C; Hofmann HS; Hillejan L; Hecker E; Semik M; Lesser T; Kugler C; Seifert S; Scheubel R
Thorac Cancer; 2022 Aug; 13(15):2158-2163. PubMed ID: 35748347
[TBL] [Abstract][Full Text] [Related]
72. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial.
Kuzdzał J; Sładek K; Wasowski D; Soja J; Szlubowski A; Reifland A; Zieliński M; Szczeklik A
Med Sci Monit; 2003 Jun; 9(6):PI54-9. PubMed ID: 12824959
[TBL] [Abstract][Full Text] [Related]
73. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
Leemans J; Dooms C; Ninane V; Yserbyt J
Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
[TBL] [Abstract][Full Text] [Related]
74. An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion.
Beck TN; Deneka AY; Chai L; Kanach C; Johal P; Alvarez NJ; Boumber Y; Golemis EA; Laub GW
BMC Cancer; 2019 Jun; 19(1):614. PubMed ID: 31234819
[TBL] [Abstract][Full Text] [Related]
75. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
Saute M
Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
[TBL] [Abstract][Full Text] [Related]
76. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
[TBL] [Abstract][Full Text] [Related]
77. [Surgical therapy for malignant pleural effusions].
Ludwig C; Stoelben E
Zentralbl Chir; 2008 Jun; 133(3):218-21. PubMed ID: 18563684
[TBL] [Abstract][Full Text] [Related]
78. Recent developments in pleurodesis for malignant pleural disease.
Guinde J; Georges S; Bourinet V; Laroumagne S; Dutau H; Astoul P
Clin Respir J; 2018 Oct; 12(10):2463-2468. PubMed ID: 30252207
[TBL] [Abstract][Full Text] [Related]
79. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak G; Metintaş M; Yildirim H; Metintaş S; Dündar E; Erginel S; Alataş F
Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
[TBL] [Abstract][Full Text] [Related]
80. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax.
Ferrante D; Arguedas MR; Cerfolio RJ; Collins BG; van Leeuwen DJ
Am J Gastroenterol; 2002 Dec; 97(12):3172-5. PubMed ID: 12492206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
